Kura Oncology, Inc. (KURA)
NASDAQ: KURA · Real-Time Price · USD
6.47
-0.02 (-0.31%)
May 2, 2025, 4:00 PM EDT - Market closed

Kura Oncology Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
May '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
5606771,0688479322,157
Upgrade
Market Cap Growth
-67.18%-36.58%26.07%-9.08%-56.80%246.13%
Upgrade
Enterprise Value
-792396334253961,847
Upgrade
Last Close Price
6.478.7114.3812.4114.0032.66
Upgrade
PS Ratio
8.2812.57----
Upgrade
PB Ratio
1.431.642.692.021.843.53
Upgrade
P/TBV Ratio
1.541.642.692.021.843.53
Upgrade
P/FCF Ratio
5.075.06----
Upgrade
P/OCF Ratio
5.045.04----
Upgrade
EV/Sales Ratio
-4.43----
Upgrade
EV/FCF Ratio
-1.78----
Upgrade
Debt / Equity Ratio
0.050.040.040.030.010.03
Upgrade
Debt / FCF Ratio
0.180.12----
Upgrade
Asset Turnover
0.110.09----
Upgrade
Quick Ratio
7.939.3212.0518.2423.1324.34
Upgrade
Current Ratio
8.079.4612.2618.5623.2624.49
Upgrade
Return on Equity (ROE)
-41.84%-42.91%-37.34%-29.31%-23.35%-21.60%
Upgrade
Return on Assets (ROA)
-19.60%-19.97%-22.89%-17.65%-13.89%-12.92%
Upgrade
Return on Capital (ROIC)
-28.07%-28.59%-24.42%-18.45%-14.40%-13.48%
Upgrade
Earnings Yield
-32.47%-25.69%-14.29%-16.04%-14.00%-4.16%
Upgrade
FCF Yield
19.74%19.76%-11.70%-13.07%-11.34%-3.34%
Upgrade
Buyback Yield / Dilution
-12.88%-17.66%-9.31%-0.96%-25.01%-26.54%
Upgrade
Updated May 1, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q